주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, March 29, 2024, 22:07
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Celltrion Healthcare: Prime Beneficiary of the Second Wave of Biosimilars
이미지기사
Finance
Kim Tae-hee
2022.08.31 09:22
Celltrion Healthcare: Conditions Met for a Virtuous Cycle Rally
이미지기사
Finance
Lee Dong-gun & Won Jae-hee
2022.08.18 11:55
Celltrion: Better Profitability, Increase in Remsima SC Market Share
이미지기사
Finance
Kim Tae-hee
2022.08.09 09:41
Celltrion: First Step toward a Virtuous Cycle Rally
이미지기사
Finance
Lee Dong-gun & Won Jae-hee
2022.08.09 09:35
Pharmaceutical/Bio: Brighter Days Ahead for Healthcare Stocks
Finance
Lee Dong-gun et al.
2022.07.04 09:53
Pharmaceutical/bio: Key Takeaways from EULAR 2022
Finance
Lee Dong-gun & Won Jae-hee
2022.06.10 13:53
Celltrion: Value of Remsima SC Reaffirmed at EULAR 2022
이미지기사
Finance
Kim Tae-hee
2022.06.08 09:35
Celltrion: 1Q22 Review: Earnings to Regain Momentum in 2H
이미지기사
Finance
Kim Tae-hee
2022.05.16 09:59
Celltrion: 4Q21 Review: Revenue Hits All-time Quarterly High
이미지기사
Finance
Kim Tae-hee
2022.02.17 10:57
Celltrion: 3Q21 Review: Earnings to Normalize in 4Q21 on Test Kit Exports
이미지기사
Finance
Kim Tae-hee
2021.11.11 09:52
Celltrion Healthcare: 1Q21 Review: Margin Erosion on Weaker U.S.-bound Exports
이미지기사
Finance
Hong Ka-hye
2021.05.18 10:31
Celltrion: 1Q21 Review: Margins Improved on Enhanced Production Efficiency
이미지기사
Finance
Hong Ka-hye
2021.05.13 11:13
Celltrion Healthcare: Expect Stronger Earnings Performance in 2H21
이미지기사
Finance
Hong Ka-hye
2021.04.30 12:40
Celltrion: Decent Earnings, Regdanvimab Holds the Key in 2021
이미지기사
Finance
Lee Dong-gun & Won Jae-hee
2021.04.19 17:05
Celltrion Healthcare: 4Q20 Review: Respite amid Increased Competition
Finance
Hong Ka-hye
2021.03.05 16:43
Celltrion: 4Q20 Review: Earnings Miss Consensus on Higher Regkirona Development Costs
이미지기사
Finance
Hong Ka-hye
2021.02.23 10:31
Pharmaceutical/bio: US Biosimilar Prescription Data for October
Finance
Lee Dong-geun & Won Jae-hee
2020.11.27 11:29
2021 Outlook: Pharmaceutical/Bio: Look to Healthcare Stocks with Post-Covid-19 Earnings Momentum
Finance
William Ku
2020.11.19 17:19
Celltrion Healthcare: Earnings Surprise Backed by Brisk U.S. Biosimilar Sales
이미지기사
Finance
Hong Ka-hye
2020.11.17 21:25
Celltrion: 3Q20 Earnings Breaks Quarterly High
이미지기사
Finance
Hong Ka-hye
2020.11.12 10:14
처음
이전
이전
1
2
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기